$23.51
Closed
-(-)

At close

Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply

About

STAAR Surgical Co. engages in the design, development, manufacture, and sale of ophthalmic surgical products. The company is headquartered in Monrovia California, California and currently employs 957 full-time employees. The firm markets and sells its ICLs for refractive surgery to treat myopia (nearsightedness) as its EVO family of lenses. Its EVO family of lenses includes its EVO ICL, EVO+ ICL, and EVO Visian ICL. The firm's newest offering, EVO Viva, has an extended depth of focus (EDoF) optic, which is designed to treat myopia with presbyopia (age-related loss of ability to focus). The company also market and sell an ICL lens to treat hyperopia (farsightedness), called Visian ICL. The company makes its ICL product offerings available in multiple models, powers and lengths, including some with toric ICL (TICL) versions to correct for astigmatism (blurred vision). The Company’s principal products are ICLs used in refractive surgery, including its EVO family of lenses.
Country

US

CEO

Mr. Warren Foust

IPO date

1992

Employees

957

ISIN

US8523123052

Key stats

Open

$23.07

Volume

698.52K

Market cap

$1.16B

Prev. close

$23.14

Impl / hst vl

-

Open interest

$0.00

$23.04

Day’s Range

$23.51

$15.59

52W Range

$35.87

Valuation

16
Valuation score
Strongly Overvalued
P/E
-
P/S
4.36
P/B
3.59
Current ratio
-
Debt / Equity
-
ROE
-
Gross margin
-
Income growth
54.78%
FCF growth
-186.71

Analysts estimates

Consensus rating
Hold

The average rating from top 9 analysts indicates that stock may significantly underperform the market

Str. Sell
Sell
Hold
Buy
Str. Buy
Avg. price target
$29.27
The top 12 analysts forecasts that 12-month price may increase by 24.52%, with a low of $20.20 and a high of $42.00
$20.20
Low
$29.27
Avg
$42.00
High
Current price

Earnings

Q3 ‘26 revenue
$93.54M
Q3 ‘26 net income
$8.06M
Revenue
Net income
Previous EPS
$0.23
Estimate EPS
$0.16
Actual EPS
Estimate EPS
Financial advisor consultation illustration
Get professional financial guidance

Schedule your free first call with a financial advisor on CUSP Wealth
*T&Cs apply